title: Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.
abstract: Nuclear cardiology imaging tests are widely performed in Japan as clinical practice. The Japanese nuclear cardiology community has developed new diagnostic imaging tests using (123)I-beta-methyl-p-iodophenyl-pentadecanoic acid, (123)I-metaiodobenzylguanidine, and (18)F-fluorodeoxyglucose PET for detecting cardiac involvement in sarcoidosis. These tests have become popular worldwide. The Japanese Circulation Society and the Japanese Society of Nuclear Cardiology have published clinical imaging guidelines showing indications and standards for the new imaging tests. JSNC is currently striving to improve the standard of clinical practice and is promoting research activities.
authors.affiliation: Molecular Imaging Research Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan, kyoshi@nirs.go.jp.
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Yoshinaga
authors.forename: Nagara
authors.initials: N
authors.lastname: Tamaki
mesh_terms: D002309:Cardiology / Q000592:standards* / Q000639:trends; D019317:Evidence-Based Medicine / Q000592:standards* / Q000639:trends; D007089:Image Enhancement / Q000592:standards; D007564:Japan; D009683:Nuclear Medicine / Q000592:standards* / Q000639:trends; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000592:standards*; D014055:Tomography, Emission-Computed / Q000592:standards* / Q000639:trends
chemical_list: D019275:Radiopharmaceuticals